Schrödinger, Inc.
SDGRHealthcareNASDAQHealth Information Services · Last scanned Oct 26, 2026
Scan Results
Daily timeframeSchrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the. With a market capitalization of $1.78B, it sits in small-cap territory. The company operates in two segments, Software and Drug Discovery.
Market Cap
$1.78B
Beta
1.62
P/E (TTM)
—
P/E (Fwd)
-17.63
EPS (TTM)
$-0.74
EPS (Fwd)
$-1.35
ROE
-16.2%
ROA
-14.4%
Cash
$413.7M
Total Debt
$108.0M
Free CF
-$29.2M
52W Change
7.3%
Annual Financials
Cash vs Debt
Where SDGR stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, SDGR finished 34.97% above its 150-day moving average ($17.13) and 40.80% above its 200-day moving average ($16.42). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SDGR overbought or oversold?
At the October 20, 2026 close, SDGR's RSI(14) was 28.7, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $413.7M in cash and $108.0M in debt, SDGR maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company is burning cash, with free cash flow at -$29.2M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -16.2%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $181.0M (2022) to $255.9M (2025), reflecting a 41% increase over the period.
Schrödinger, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. With cash comfortably exceeding debt, SDGR has financial flexibility that may help navigate uncertain periods. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. No single metric tells the full story. Reviewing SDGR's risk profile alongside its fundamentals and technical indicators provides a more complete picture.